Oseltamivir 30 mg Once Daily Dosing
Yes, oseltamivir 30 mg once daily is appropriate for both pediatric prophylaxis in children weighing ≤15 kg (≤33 lbs) and for adult prophylaxis in patients with creatinine clearance 10-30 mL/min.
Pediatric Dosing (15-23 kg Weight Range)
For children weighing 15-23 kg (33-51 lbs), the correct prophylaxis dose is 45 mg once daily, NOT 30 mg once daily 1, 2, 3. The 30 mg once daily dose is reserved for children weighing ≤15 kg (≤33 lbs) 1, 4, 5, 2, 3.
Weight-Based Pediatric Prophylaxis Dosing:
- ≤15 kg (≤33 lbs): 30 mg once daily
- 15-23 kg (33-51 lbs): 45 mg once daily
- 23-40 kg (51-88 lbs): 60 mg once daily
- >40 kg (>88 lbs): 75 mg once daily
All prophylaxis regimens continue for 10 days after exposure 1, 2, 3.
Renal Impairment Dosing
For patients with creatinine clearance 10-30 mL/min, the 30 mg once daily dose is explicitly recommended for prophylaxis 6, 5, 3. An alternative regimen of 75 mg every other day for 10 days (5 total doses) is also acceptable 6, 5.
Key Renal Dosing Points:
- Treatment (CrCl 10-30 mL/min): 75 mg once daily for 5 days
- Prophylaxis (CrCl 10-30 mL/min): 30 mg once daily for 10 days OR 75 mg every other day for 10 days
Critical Caveat for Renal Dosing:
Recent evidence suggests that current dose reductions for mild-to-moderate renal impairment may be suboptimal 7. The standard reduced doses focus on achieving steady-state concentrations similar to those in patients with normal renal function, but they fail to achieve therapeutic concentrations early enough in the infection course when antiviral efficacy is most critical. Consider using the full 75 mg initial dose followed by reduced maintenance doses proportional to renal function, with therapeutic drug monitoring when available 7.
Special Populations
End-Stage Renal Disease on Hemodialysis:
For ESRD patients on hemodialysis, 30 mg after each HD session is the optimal treatment regimen, producing appropriate trough concentrations without safety concerns 8. For prophylaxis in HD patients, 30 mg after every other HD session is recommended 8.
Automated Peritoneal Dialysis:
A single 75 mg dose produces adequate exposures in APD patients with minimal residual renal function, though higher doses may be needed for those with significant residual urine production 9.
Large Body Mass:
Current dosing recommendations do not adequately account for larger body mass. Patients with obesity may require proportionately larger initial doses (>75 mg) to achieve therapeutic concentrations early in infection 7.
Administration Considerations
Oseltamivir may be taken with or without food, though administration with meals may enhance tolerability 1, 2, 3. The oral suspension concentration is 6 mg/mL in current formulations 1, 2, 3, providing:
- 30 mg dose = 5 mL
- 45 mg dose = 7.5 mL
- 60 mg dose = 10 mL
- 75 mg dose = 12.5 mL
If capsules must be used in children who cannot swallow them whole, they may be opened and mixed with sweetened liquids 1, 2, 3.